OrbusNeich Medical Group Holdings (HKSE:06929) Inventories, Raw Materials & Components: HK$292 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06929 OrbusNeich Medical Group Holdings Ltd HKSE:06929
95 GF Score
Price HK$3.83
GF Value HK$5.30
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is OrbusNeich Medical Group Holdings Inventories, Raw Materials & Components?

OrbusNeich Medical Group Holdings HKSE:06929 -0.52% 95 Inventories, Raw Materials & Components is HK$292 Mil as of Dec. 2025. GuruFocus rates HKSE:06929 with a GF Score™ of 95/100 and a GF Value™ of HK$5.30 (Modestly Undervalued). The stock has 2 warning signs investors should review.

OrbusNeich Medical Group Holdings's inventories, raw materials & components for the quarter that ended in Dec. 2025 was HK$292 Mil.

OrbusNeich Medical Group Holdings's quarterly raw materials declined from Dec. 2024 (HK$255 Mil) to Jun. 2025 (HK$0 Mil) but then increased from Jun. 2025 (HK$0 Mil) to Dec. 2025 (HK$292 Mil).

OrbusNeich Medical Group Holdings's annual raw materials increased from Dec. 2023 (HK$167 Mil) to Dec. 2024 (HK$255 Mil) and increased from Dec. 2024 (HK$255 Mil) to Dec. 2025 (HK$292 Mil).

OrbusNeich Medical Group Holdings Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for OrbusNeich Medical Group Holdings's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrbusNeich Medical Group Holdings Inventories, Raw Materials & Components Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 110.20 117.37 167.47 255.42 291.55

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 255.42 0.00 291.55 0.00
HKSE:06929
95GF Score
OrbusNeich Medical Group Holdings Ltd HKSE:06929
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OrbusNeich Medical Group Holdings Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of HK$292 Mil mean?
OrbusNeich Medical Group Holdings (HKSE:06929) has a Inventories, Raw Materials & Components of HK$292 Mil as of Dec. 2025. Raw materials are the components a company uses for its main products. View historical data on OrbusNeich Medical Group Holdings and its competitors.
Is OrbusNeich Medical Group Holdings' Inventories, Raw Materials & Components too high?
OrbusNeich Medical Group Holdings' current Inventories, Raw Materials & Components is HK$292 Mil. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' Inventories, Raw Materials & Components compare to ISRG and BDX?
OrbusNeich Medical Group Holdings' Inventories, Raw Materials & Components of HK$292 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on OrbusNeich Medical Group Holdings and its competitors. OrbusNeich Medical Group Holdings's current Inventories, Raw Materials & Components is HK$292 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings (HKSE:06929) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$5.30, compared to a current price of HK$3.83 — trading 27.7% below its estimated fair value. The current Inventories, Raw Materials & Components is HK$292 Mil. OrbusNeich Medical Group Holdings' overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (HKSE:06929), the current Inventories, Raw Materials & Components is HK$292 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OrbusNeich Medical Group Holdings (HKSE:06929) Overvalued in 2026?

Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued. The current stock price of HK$3.83 is trading 27.7% below its estimated GF Value™ of HK$5.30. GuruFocus considers OrbusNeich Medical Group Holdings to be Modestly Undervalued.

Key valuation signals for HKSE:06929:

  • Inventories, Raw Materials & Components: HK$292 Mil
  • GF Value™: HK$5.30 vs. price of HK$3.83 (27.7% below fair value)
  • GF Score™: 95/100 with 2 warning signs

No single metric tells the full story. See the HKSE:06929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OrbusNeich Medical Group Holdings Business Description

Address 3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
95GF Score

Get the complete analysis for HKSE:06929

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$3.83
Price
HK$5.30
GF Value